1'752 companies found
Effectum Medical AG
Olten · Since 2017
Effectum Medical AG provides regulatory and quality‑management services for medical technology companies. Its offerings include ISO 13485‑compliant plug‑and‑play QMS, outsourced legal manufacturer services for MDR/IVDR CE‑marking, on‑demand QA/RA experts, regulatory opinions, and AI/ML compliance support.
EFFIK SA
Nyon · Since 2006
EFFIK SA is a pharmaceutical company specializing in the development, manufacture, and distribution of medicines, medical devices, and dietary supplements. The company's core activities include: * Research and development of new therapies and products, particularly in the fields of gynecology, neurology, hematology, and cardiology * Manufacturing and distribution of medicines, medical devices, and dietary supplements * Development of solutions for specific patient groups, such as women in various life situations (e.g. pregnancy, menopause) * Collaboration with medical experts and physicians to develop innovative solutions and improve patient care The company focuses on developing products tailored to the specific needs of patients and healthcare providers, and values quality, innovation, and patient proximity.
EffRx Pharmaceuticals SA
Freienbach · Since 2009
The core activity of EffRx Pharmaceuticals SA is the development, approval and marketing of medicines for rare and niche diseases in Europe and Switzerland. The company focuses particularly on the late-stage development and market entry of therapeutics for patients with rare diseases such as osteoporosis, adrenal insufficiency, congenital adrenal hyperplasia and Niemann-Pick disease. EffRx works closely with partners to develop and bring new medicines to market, offering accelerated decision-making processes and rapid market entry for its customers.
EHC (EUROPEAN HEALTH CORPORATION) SA
Geneva · Since 2010
EHC (EUROPEAN HEALTH CORPORATION) SA develops and commercializes consumer healthcare and self-care products, including OTC medicines, medical devices and dietary supplements. The company conducts acquisitions, in-/out-licensing, distribution and brand promotion, and partners with distributors and laboratories to bring its products to market.
Eisai Pharma AG
Zurich · Since 2005
Eisai Pharma AG is a research and development-oriented pharmaceutical company specializing in the research, development, and distribution of products in the fields of neurology and oncology. The company's core activity is the development and provision of innovative treatment options for patients with severe illnesses, particularly in the fields of neurology and oncology.
Elanco Tiergesundheit AG
Basel · Since 1997
The core activity of Elanco is the development and manufacture of animal health medicines and products that improve the health, well-being and performance of animals, as well as providing services and solutions for animal health.
Elixan Aromatica GmbH
Gähwil · Since 1995
The core activity of Elixan Aromatica Pharma GmbH is the manufacture and distribution of aromatherapy products, essential oils, phytopharmaceuticals and medicinal products. The company also offers private-label solutions, where it manufactures products for other companies and equips them with the label and packaging of the client.
Elthera AG
Zug · Since 2016
The core activity of Elthera AG is the development of precision medicine oncology solutions, particularly the research and development of L1CAM-based immunotherapies to combat aggressive tumors.
Enable Biotech AG
Zug · Since 2023
The core activity of Enable Biotech is the development and manufacturing of cell and gene therapies (ATMPs) as well as exosome therapies for clinical trials. The company offers Contract Development and Manufacturing Organization (CDMO) services, including process development, clinical manufacturing, quality control, and regulatory support. Enable Biotech focuses on the needs of start-ups and small companies in the field of advanced therapies, providing flexible and cost-effective solutions for the production of cell and gene therapies.
Endogena Therapeutics AG
Zurich · Since 2020
The core activity of Endogena Therapeutics is the development of therapies to repair damaged tissue by activating the body's own regenerative capabilities. To achieve this, the company combines artificial intelligence with years of experience in drug development to identify small molecules that can specifically activate the body's own stem cells. A key focus is on the development of therapies for inherited blindness and other degenerative diseases.
ENWOTEC AG
St. Gallen · Since 2022
The core activity of ENWOTEC AG is the development and provision of filtration solutions and products for various industries, including water treatment, biotechnology, food and beverage, chemicals, plasmapheresis, cosmetics, flavors and fragrances, as well as cannabis. The company offers a wide range of filtration products, including filter cartridges, functional granulates, functional membranes, depth filter pads, lens modules, activated carbon filter paper, and single-use solutions. In addition, ENWOTEC AG provides consulting services for the optimization of filtration processes.
enzymmanagement ag
Tägerwilen · Since 2007
enzymmanagement ag develops and produces bioactive cosmeceutical and topical treatments targeting benign fatty‑tissue tumors and certain rare diseases such as multiple symmetric lipomatosis and estradiol‑dependent breast cancer. Its developments are based on intracrinological and biochemical principles of local steroid production and metabolism in target tissues.
EpiPharm AG
Binningen · Since 2007
EpiPharm AG is a clinical-stage biotechnology company developing topical treatments and dermato-cosmetic products based on multi-active, plant-derived compositions that include artemisinin derivatives. Its projects address skin disorders such as seborrhoeic keratosis and pigmented lesions, and the company offers co-development and licensing opportunities for its pipeline.
Epithelix Sàrl
Plan-Les-Ouates · Since 2006
Epithelix Sàrl develops and supplies in vitro reconstituted human respiratory tissue models and associated culture media, including MucilAir™, SmallAir™ and AlveolAir™. The company also provides laboratory testing services (CRO), such as viral and bacterial infection assays, inhalation toxicity testing, nasal spray evaluation and mucociliary endpoint analyses.
EQX Healthcare AG
Baar · Since 2024
EQX Healthcare AG produces and sells natural dietary supplements for horses, developing formulations with veterinarians to support digestive health, metabolism, respiratory function and the musculoskeletal system.
EraCal Therapeutics AG
Basel · Since 2018
The core activity of EraCal Therapeutics is the development of solutions to combat obesity (obesity) based on scientific research.
ESC Biotech Swiss AG
Basel · Since 2018
ESC Biotech Swiss AG is a biotechnology and pharmaceutical manufacturing company offering end-to-end CDMO services for cell and gene therapies and vaccines. Services include process development, fill-and-finish, quality and regulatory support, program/project management, modular production suites, laboratories, cryostorage and a proprietary Process Reinforcement Technology (PRT).
Eugenex Biotechnologies GmbH
Tägerwilen · Since 1999
Eugenex Biotechnologies GmbH develops expression cell lines and process solutions for animal component‑free production of biosimilars and novel biopharmaceuticals. The GeneXpress technology platform includes CHOSI host cell lines, protein‑free MAM‑PF media and pMOZ expression plasmids, and the company offers ready‑to‑go biosimilar processes, cell line and process development, gram‑scale protein production (non‑GMP), analytical and cell‑based assays and technology transfer.
Eurofins NSC Schweiz AG
Schönenwerd · Since 2020
EvlaBio AG
Zurich · Since 2022
The core activity of EvlaBio AG is the development of therapeutics, particularly first-in-class therapeutics in the field of cardiovascular and cardio-renal diseases. The focus is on the development of therapeutic monoclonal antibodies (mAb) that target specific target molecules such as FGFR4/FGF23 to treat chronic kidney diseases (CKD).
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register